Clinical Trial Update: EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating EVM16 injection alone and in combination with tislelizumab in advanced or recurrent solid tumors; study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• EVM16 Injection
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Peking University | Conditions: Advanced or Recurrent Solid Tumors | Phase 1 | Status: RECRUITING